Start with the plant, rather than the marketing name
Goldenseal is Hydrastis canadensis, a plant with a yellow rhizome, or underground stem. NCCIH notes both overharvesting and commercial cultivation. Its original generated illustration here represents the plant ingredient; it does not verify species, plant part, purity or a commercial product.See reference 1
Separate three different kinds of claim
- Claim
- Colds, digestive complaints or other promoted uses
- What the evidence supports
- NCCIH finds insufficient evidence to determine usefulness; rigorous human efficacy studies are lackingSee reference 1
- Claim
- Benefits reported for isolated berberine
- What the evidence supports
- Those results cannot automatically be transferred to oral goldensealSee reference 1
- Claim
- Changes in medicine exposure
- What the evidence supports
- Human interaction studies exist; they answer a different question from whether goldenseal is an effective treatmentSee reference 2,See reference 3
Why one metformin percentage does not fit every person
- Study
- 2021 probe study · 16 healthy volunteers
- Finding and limitation
- Metformin exposure was lower with goldenseal: the geometric mean exposure ratio was 0.77. This was a small interaction study, not a diabetes-treatment trialSee reference 2
- Study
- 2025 open-label crossover study · 22 adults with type 2 diabetes
- Finding and limitation
- The overall metformin exposure ratio was 0.93, inside the study’s prespecified no-effect range. Subgroup changes differed with metformin doseSee reference 3
The later study adds nuance; it does not clear the combination
In the 2025 study, exposure reductions were larger in lower-dose metformin subgroups and smaller at higher doses. The subgroups were small. The authors also found that exploratory glucose-control changes did not simply follow drug-exposure changes. An overall average cannot guarantee an individual combination is harmless.See reference 3
This open-label interaction study did not establish goldenseal as a diabetes treatment or justify changing metformin, adding goldenseal or selecting a separation interval.See reference 3
The interaction question extends beyond metformin
The 2021 study also found higher exposure to midazolam, a medicine used as a probe of CYP3A metabolism. It did not find the same effect for every tested medicine. This illustrates why a general herb-interaction label cannot predict the direction or size of an effect for an untested drug.See reference 2
Keep the exact goldenseal product, ingredients, amount and medicine list available for a pharmacist or clinician. This guide cannot clear a combination or select a washout period.
Product identity and special-population safety remain important
NCCIH advises against goldenseal in pregnancy, breastfeeding and infants, and reports uncertainty about longer-term safety. It also describes mislabeled products containing other ingredients. A yellow powder or a familiar brand name does not establish authenticity.See reference 1
A supplement quality check and proof of benefit are separate questions. In the United States, supplements do not receive medicine-style FDA approval before sale; other jurisdictions use different systems. A product’s legal availability does not establish that its health claims have been proven.See reference 4
Keep the useful details
- Do not borrow efficacy findings from a different ingredient.See reference 1
- Read an interaction result with its population and study design.See reference 2,See reference 3
- A short study cannot settle every long-term or medicine-combination question.See reference 1,See reference 3
Common questions
Is goldenseal the same supplement as berberine?
No. Goldenseal is a botanical preparation containing several constituents. Results for isolated berberine do not establish benefits for goldenseal.See reference 1
Does it always reduce metformin exposure by about a quarter?
No. The later diabetes study found a smaller overall average effect and dose-dependent subgroup findings. It does not provide personal combination clearance.See reference 3
Is there an evidence-based dose for treating a cold?
The cited evidence does not establish that goldenseal treats a cold or define an effective treatment dose.See reference 1
Get the weekly longevity brief
The week's best longevity research in plain English. Free, every Tuesday.
References
- 1. Goldenseal: usefulness and safety
NCCIH, U.S. National Institutes of Health; updated February 2025Official guidance
- 2. Assessing transporter-mediated natural product-drug interactions: clinical evaluation with a probe cocktail
Nguyen and colleagues, Clinical Pharmacology and Therapeutics; 2021Nonrandomized human study
- 3. The goldenseal-metformin interaction is metformin dose-dependent: a three-arm crossover study
Nguyen and colleagues, Clinical and Translational Science; 2025Nonrandomized human study
- 4. Questions and answers on dietary supplements
U.S. Food and Drug AdministrationOfficial guidance
Editorial transparency
- Published by
- LongevityMate Editorial
- Review
- Editorial evidence review (AI-assisted)
- Published
- Updated
Medical disclaimer
General education only. AI-assisted editorial evidence review is not a qualified clinical assessment. This guide does not diagnose a condition, interpret a personal result, choose treatment or recommend a supplement dose. Discuss testing, symptoms, medicines and supplements with a qualified health professional.
